These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

2459 related items for PubMed ID: 23542330

  • 1. Health benefits and cost-effectiveness of a hybrid screening strategy for colorectal cancer.
    Dinh T, Ladabaum U, Alperin P, Caldwell C, Smith R, Levin TR.
    Clin Gastroenterol Hepatol; 2013 Sep; 11(9):1158-66. PubMed ID: 23542330
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Cost effectiveness and projected national impact of colorectal cancer screening in France.
    Hassan C, Benamouzig R, Spada C, Ponchon T, Zullo A, Saurin JC, Costamagna G.
    Endoscopy; 2011 Sep; 43(9):780-93. PubMed ID: 21623557
    [Abstract] [Full Text] [Related]

  • 4. Screening based on risk for colorectal cancer is the most cost-effective approach.
    Dan YY, Chuah BY, Koh DC, Yeoh KG.
    Clin Gastroenterol Hepatol; 2012 Mar; 10(3):266-71.e1-6. PubMed ID: 22100624
    [Abstract] [Full Text] [Related]

  • 5. Cost-effectiveness simulation and analysis of colorectal cancer screening in Hong Kong Chinese population: comparison amongst colonoscopy, guaiac and immunologic fecal occult blood testing.
    Wong CK, Lam CL, Wan YF, Fong DY.
    BMC Cancer; 2015 Oct 15; 15():705. PubMed ID: 26471036
    [Abstract] [Full Text] [Related]

  • 6. Cost-effectiveness and budget impact analyses of colorectal cancer screenings in a low- and middle-income country: example from Thailand.
    Phisalprapa P, Supakankunti S, Chaiyakunapruk N.
    J Med Econ; 2019 Dec 15; 22(12):1351-1361. PubMed ID: 31560247
    [Abstract] [Full Text] [Related]

  • 7. Cost-effectiveness analysis on screening for colorectal neoplasm and management of colorectal cancer in Asia.
    Tsoi KK, Ng SS, Leung MC, Sung JJ.
    Aliment Pharmacol Ther; 2008 Aug 01; 28(3):353-63. PubMed ID: 18638075
    [Abstract] [Full Text] [Related]

  • 8.
    Whitlock EP, Lin J, Liles E, Beil T, Fu R, O'Connor E, Thompson RN, Cardenas T.
    ; 2008 10 01. PubMed ID: 20722162
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Cost-effectiveness of the faecal immunochemical test at a range of positivity thresholds compared with the guaiac faecal occult blood test in the NHS Bowel Cancer Screening Programme in England.
    Murphy J, Halloran S, Gray A.
    BMJ Open; 2017 Oct 27; 7(10):e017186. PubMed ID: 29079605
    [Abstract] [Full Text] [Related]

  • 14. Cost-effectiveness analysis of colorectal cancer screening methods in Iran.
    Allameh Z, Davari M, Emami MH.
    Arch Iran Med; 2011 Mar 27; 14(2):110-4. PubMed ID: 21361717
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Screening for Colorectal Cancer With Fecal Immunochemical Testing With and Without Postpolypectomy Surveillance Colonoscopy: A Cost-Effectiveness Analysis.
    Greuter MJE, de Klerk CM, Meijer GA, Dekker E, Coupé VMH.
    Ann Intern Med; 2017 Oct 17; 167(8):544-554. PubMed ID: 28973514
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 123.